CRRC Corporation (601766.SH) has recently accumulated a total of 34.89 billion yuan in signed contracts.

04/03/2024

GMT Eight

CRRC Corporation (601766.SH) announced that it has signed several contracts totaling approximately 34.89 billion yuan between December 2023 and March 2024, accounting for about 15.7% of the company's revenue in 2022 under Chinese accounting standards.

Shanghai Jinqiao Export Processing Zone Development (600639.SH): Net profit for the year 2023 is 1.819 billion yuan, an increase of 14.85% year-on-year.

Zhuhai Rundu Pharmaceutical(002923.SZ): Application for the listing permit of Methoxamine Hydrochloride Injection has been accepted.

Contact: contact@gmteight.com

CRRC Corporation (601766.SH) has recently accumulated a total of 34.89 billion yuan in signed contracts.

RECOMMEND

SILKWAVE INC (00471) has completed the issuance of 5.7 million subscribed shares.

The US SEC halts investigation into Robinhood (HOOD.US), signs of loosening regulations in the cryptocurrency industry.

Morgan Stanley: "Overweight" rating on CSPC PHARMA (01093), raises target price to 6.8 Hong Kong dollars.